• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咪唑啉受体对α(2A)-去甲肾上腺素能受体的细胞内作用

Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor.

作者信息

Chen Michael J, Zhu H E, Piletz John E

机构信息

California State University, Los Angeles, California 90032, USA.

出版信息

Ann N Y Acad Sci. 2003 Dec;1009:427-38. doi: 10.1196/annals.1304.057.

DOI:10.1196/annals.1304.057
PMID:15028622
Abstract

Imidazoline-1 receptors (I(1)R) and alpha(2)-noradrenergic receptors (alpha(2)AR) are known to coexist in many cell types and bind many of the same imidazoline ligands. Herein, the possibility of an interaction between these receptors was explored using a cloned cDNA that encodes a protein with I(1)R-like binding properties, designated imidazoline receptor antisera-selected (IRAS). Chinese hamster ovary (CHO) sublines permanently expressing the human subtype alpha(2A)AR cDNA were transiently cotransfected with the human IRAS cDNA (pIRAS). Saturation radioligand binding experiments on membranes isolated from the various sublines allowed distinction between I(1)R and alpha(2A)AR. Transfection of pIRAS into either subline led to a rise in membrane I(1)R-binding sites. Immunoblotting revealed that IRAS was enriched in membranes more than in cytosolic fractions. Transfection of pIRAS in CHO cells harboring the alpha(2A)AR cDNA resulted in a twofold increase in alpha(2A)AR binding sites with no change in alpha(2A)AR binding affinity, compared with controls. Immunoblotting also revealed increased expression of membranous alpha(2A)AR by IRAS. Thus, pIRAS transfection led to I(1) binding sites and to an increase in alpha(2A)AR binding sites in CHO cells expressing the human alpha(2A)AR. Although the mechanism is unclear, this increase in binding sites may explain previous imidazoline drug effects suggestive of interactions between these two receptors.

摘要

已知咪唑啉 -1 受体(I(1)R)和α(2)-去甲肾上腺素能受体(α(2)AR)在许多细胞类型中共存,并结合许多相同的咪唑啉配体。在此,使用一种克隆的 cDNA 探索了这些受体之间相互作用的可能性,该 cDNA 编码一种具有 I(1)R 样结合特性的蛋白质,命名为咪唑啉受体抗血清选择蛋白(IRAS)。将永久表达人α(2A)AR cDNA 的中国仓鼠卵巢(CHO)亚系与人类 IRAS cDNA(pIRAS)进行瞬时共转染。对从各种亚系中分离出的膜进行饱和放射性配体结合实验,可区分 I(1)R 和α(2A)AR。将 pIRAS 转染到任一亚系中都会导致膜 I(1)R 结合位点增加。免疫印迹显示,IRAS 在膜中的富集程度高于胞质部分。与对照相比,将 pIRAS 转染到携带α(2A)AR cDNA 的 CHO 细胞中,导致α(2A)AR 结合位点增加了两倍,而α(2A)AR 结合亲和力没有变化。免疫印迹还显示 IRAS 使膜性α(2A)AR 的表达增加。因此,pIRAS 转染导致表达人α(2A)AR 的 CHO 细胞中出现 I(1)结合位点,并使α(2A)AR 结合位点增加。尽管其机制尚不清楚,但结合位点的这种增加可能解释了先前咪唑啉药物效应所暗示的这两种受体之间的相互作用。

相似文献

1
Intracellular effect of imidazoline receptor on alpha(2A)-noradrenergic receptor.咪唑啉受体对α(2A)-去甲肾上腺素能受体的细胞内作用
Ann N Y Acad Sci. 2003 Dec;1009:427-38. doi: 10.1196/annals.1304.057.
2
Imidazoline receptor antisera-selected (IRAS) cDNA: cloning and characterization.咪唑啉受体抗血清筛选的(IRAS)互补DNA:克隆与特性分析
DNA Cell Biol. 2000 Jun;19(6):319-29. doi: 10.1089/10445490050043290.
3
Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.人I1-咪唑啉结合位点与α-2肾上腺素能受体亚型高亲和力状态下配体结合亲和力的比较。
J Pharmacol Exp Ther. 1996 Nov;279(2):694-702.
4
Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.具有激动剂、沉默和反向激动剂特性的配体增强野生型和组成型活性α(2A)-肾上腺素能受体的稳定性。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Aug;366(2):134-41. doi: 10.1007/s00210-002-0562-x. Epub 2002 Jun 6.
5
Quantitative autoradiographic localization in rat brain of alpha 2-adrenergic and non-adrenergic I-receptor binding sites labelled by [3H]rilmenidine.用[³H]瑞米吉仑标记的大鼠脑内α₂-肾上腺素能和非肾上腺素能I型受体结合位点的定量放射自显影定位
Brain Res. 1995 Mar 27;675(1-2):264-78. doi: 10.1016/0006-8993(95)00083-3.
6
Inverse agonist activity at the alpha(2A)-adrenergic receptor.α₂A-肾上腺素能受体的反向激动剂活性。
Mol Pharmacol. 2001 Mar;59(3):532-42. doi: 10.1124/mol.59.3.532.
7
Modulation of agmatine on calcium signal in morphine-dependent CHO cells by activation of IRAS, a candidate for imidazoline I1 receptor.胍丁胺通过激活咪唑啉I1受体候选物IRAS对吗啡依赖的CHO细胞钙信号的调节作用。
Eur J Pharmacol. 2006 Oct 24;548(1-3):21-8. doi: 10.1016/j.ejphar.2006.07.013. Epub 2006 Jul 22.
8
IRAS splice variants.胰岛素抵抗动脉粥样硬化综合征剪接变体
Ann N Y Acad Sci. 2003 Dec;1009:419-26. doi: 10.1196/annals.1304.056.
9
Mechanisms regulating the cell surface residence time of the alpha 2A-adrenergic receptor.
Biochemistry. 2000 Feb 1;39(4):693-700. doi: 10.1021/bi9920275.
10
Cell signaling by imidazoline-1 receptor candidate, IRAS, and the nischarin homologue.咪唑啉-1受体候选物IRAS和尼查林同源物的细胞信号传导
Ann N Y Acad Sci. 2003 Dec;1009:392-9. doi: 10.1196/annals.1304.053.

引用本文的文献

1
Regulation of I1-imidazoline receptors on the sedation effect of dexmedetomidine in mice.I1-咪唑啉受体对右美托咪定镇静作用的调节。
Naunyn Schmiedebergs Arch Pharmacol. 2024 Aug;397(8):5927-5937. doi: 10.1007/s00210-024-02991-2. Epub 2024 Feb 16.
2
Role of Nischarin in the pathology of diseases: a special emphasis on breast cancer.Nischarin 在疾病发病机制中的作用:特别关注乳腺癌。
Oncogene. 2022 Feb;41(8):1079-1086. doi: 10.1038/s41388-021-02150-4. Epub 2022 Jan 22.
3
Platelet imidazoline receptors as state marker of depressive symptomatology.
血小板咪唑啉受体作为抑郁症状的状态标志物。
J Psychiatr Res. 2008 Jan;42(1):41-9. doi: 10.1016/j.jpsychires.2006.10.011. Epub 2006 Dec 12.